small molecule

ACANYA

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Loss of exclusivityAugust 2029latest FDA-listed patent expiry
CompanyBAUSCH HEALTH AMERICAS INC

Drug detail

Brand nameACANYA
Active ingredientBENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Strength2.5%;EQ 1.2% BASE
Dosage formGEL
RouteTOPICAL
ModalitySmall molecule
FDA approvalOctober 2008
Marketing statusRX

Listed patents

PatentExpiresType
8288434August 2029product
8895070June 2029use U-124
10220049June 2029product
10624918June 2029use U-916
8663699June 2029use U-124
9078870June 2029product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ACANYA patent cliff — loss of exclusivity August 2029 | CliffBio